MIT Tech Review

When AI designs a drug, who gets the credit?

When the biotech company Insilico Medicine used its computer models to propose a promising drug for pulmonary fibrosis, it enthusiastically claimed in a press release that the molecule had been “discovered by” its generative AI platform.

This is a short WorldPing brief. The full report was published by MIT Tech Review.

Read the full report at MIT Tech Review

Related news